Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-180-0 | CAS number: 68783-04-0 A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
TDAEs: IP 346 > 3%:
Dermal application of radio labelled distillate aromatic extract in the pregnant rat resulted in low levels of uptake of key constituents in maternal tissues. Very low levels of radioactivity were detected in the foetus.
TDAEs: IP 346 < 3%
In key animal toxicity studies that investigated the toxicokinetic activity of highly refined base oils, no mortalities were observed. Highly refined base oils were not well absorbed overall, with <5% absorbed and the rest excreted in the faeces. Orally administered, sufficiently refined hydrocarbons (hydrotreated highly refined base oils) were observed to have metabolized to the corresponding fatty acids of the same carbon chain length as the parent carbons, suggesting omega oxidation (in male and female rats). Simple mixtures of aliphatic hydrocarbons (IP 346 < 3%) when orally administered to CD male rats demonstrated that percentage retention was inversely proportional to the number of carbon atoms and ranged from 60% for C14 to 5% for C28 compounds, the small intestine being the major site of absorption. Both oral and i.p. routes of administration exhibited the same characteristics of absorption in studies conducted in rats.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
Treated distillate aromatic extracts (TDAEs) are a further processing of untreated distillate aromatic extracts (UDAEs) in an attempt to reduce the amount of 3-7 ring PAC that is present. Since the treatment is mostly a selective reduction of PACs, the data from UDAEs can serve as read across where treatment was insufficient and a significant amount of PACs still remain (≥ 3 wt% DMSO extractables as measured by IP-346). Where treatment was sufficient to reduce the 3-7 ring PACs (<3 wt% DMSO extractables as measured by IP-346), the material is most similar to refined lubricating base oils and these data can be used for read across.
TDAEs (IP 346 ≥ 3 wt%)
In a key read across bioavailability toxicokinetics study in pregnant rats, 1000 mg/kg of radiolabelled 318 isthmus furfural extract (an untreated distillate aromatic extract) was dermally applied on gestation days 10, 11, and 12 (Mobil 1989; Klimisch score = 2). Maternal tissues, blood, placentas, uteri, embryos, and yolk sacs were collected and analyzed for radioactivity on gestation day 13 following sacrifice. Urine, faeces, and cage wash was collected every 24 hours and also analyzed for radioactivity.
Dermal absorption of 14C-carbazole occurred more extensively than did 3H-benzo(a)pyrene over a 72 hour period. About 19.9% and 4.1% of the total applied of 14C-carbazole and 3H-benzo(a)pyrene, respectively, was dermally absorbed. Of the total absorbed dose of 14-C-carbazole, 2.1% was found in the maternal tissues and less than 0.01% was detected in the embryo. Of the total absorbed dose of 3H-benzo(a)pyrene 1.8% was detected in the maternal tissue and less than 0.01% was found in the embryo. 17.7% of 14C-carbazole was excreted in the urine and faeces over 72 hours. 2.3% of 3Hbenzo(a)pyrene was excreted in the urine and faeces over 72 hours.
Based on the bioavailability results, neither of the radiolabelled components of 318 isthmus furfural extract were found to selectively accumulate in the embryo.
Mutagenicity and carcinogenicity of a series of 39 petroleum oils, including several DAEs, were correlated with the content of 3-7 ring PACs. Further, the steady-state dermal penetration of PAC in long-term testing was also determined predominantly by PAC concentration. Although aromaticity and viscosity had a minimal effect on dermal penetration, neither was an important determinant of the carcinogenic potency.
Substances in this category are UVCBs; hence it is not possible to apply standard methodology for assessing absorption, distribution and metabolism. Relevant data for use in risk assessment are available for constituent compounds.
TDAEs (IP 346 < 3 wt%)
In a basic key read across toxicokinetics study (Baldwin et al., 1992; Klimisch score = 2), a group of male and female rats were fed oleum-treated highly refined base oil and hydrotreated highly refined base oil in concentrations of 5000, 10000, 20000 ppm and a group of female rats were fed OTWO and HTWO in concentrations of 10, 100, 500, 1000, 10000, 20000 ppm for a period of 13 weeks. Animals were euthanized at the conclusions of the study, after which haematological, clinical chemistry, gross necropsy, tissue residue, and histopathological examination were performed.
Pathological findings in the test animals were quantitatively similar to those previously associated with the ingestion of mineral hydrocarbons by a range of species, but the effects occurred at much lower levels of dietary intake than previously reported. No pathological changes were observed after 25 days of feeding, but after 90 days there were very slight to moderate multifocal granulomatous changes in mesenteric lymph nodes and liver. Although rats fed the oleum-treated highly refined base oil were more affected than those fed the hydrotreated highly refined base oil differences in the specification of each oil rather than processing method were more likely to have accounted for the variation. The insufficiently refined hydrocarbons oleum-treated highly refined base oils are suggested to undergo a process of omega oxidation. The sufficiently refined hydrocarbons (hydrotreated highly refined bas oils; IP 346 <3%) are metabolized to the corresponding fatty acids of the same carbon chain length as the parent carbons, suggesting omega oxidation.
A supporting read across toxicokinetics study performed by Albro et al. (1970; Klimisch score = 2) evaluated absorption of hydrocarbon mixtures (IP 346 <3%). Simple mixtures of aliphatic hydrocarbons were administered to CD male rats by gastric intubation at dose levels of up to 500 mg/kg b.w. The percentage retention of the aliphatic hydrocarbons was inversely proportional to the number of carbon atoms and ranged from 60% for C14 to 5% for C28 compounds. The major site of absorption was found to be the small intestine.
A supporting read across toxicokinetic study performed by Ebert et al. (1966; Klimisch score = 2) evaluated the distribution of mineral oil (IP 346 < 3%) administered orally and via i.p. injection. Male and female Sprague-Dawley and Holtzman rats were treated orally and via i.p. injection with 0.66 mg/kg bw of non-labelled mineral oil for 31 consecutive days. Tritiated mineral oil was given on the thirty-second day,as at final dose. Both oral and i.p. routes of administration exhibited the same characteristics of absorption. Results indicated that radioactivity was found in liver, fat, kidney, brain, and spleen. After oral administration, the concentration of tritiated mineral oil decreased rapidly to 0.3% within 2 days post treatment and very slowly by day 21 indicating a very low absorption. After i.p administration the extraction was very slow: 11% was found in faeces within 8 days post treatment and negligible traces were found in urine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.